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Abstract  
 
Introduction: 
Cauda equina secondary to metastatic follicular thyroid cancer of the lumbosacral area is a 
rare entity.  
 
Case Report: 
We report an unusual case of a 52-year-old male who presented with backache, lower limb 
weakness, and perianal numbness. A CT-scan of the lumbosacral area showed an enhancing mass 
at the L4, L5 and S1 vertebrae. Histopathology after excision revealed a metastatic thyroid cancer. 
Hence, a CT scan of the neck and chest was performed which showed a nodule in the left lobe of 
the thyroid and a mass in the left chest wall. A total thyroidectomy and excision of the chest wall 
lesion was undergone, which was diagnosed as a follicular carcinoma of the thyroid.  
 
Conclusion:   
Metastatic workup of spinal metastasis should include evaluation of the thyroid gland. 
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Introduction  
Thyroid cancer is an entity that accounts 
for approximately 1% of all newly occurring 
malignant cancers. It accounts for 0.5% of 
cancers in men and 1.5% in women (1,2). 
Thyroid cancers are broadly divided into 
two categories. Differentiated thyroid cancer 
(DTC) accounts for most malignancies i.e 
90% of all thyroid cancers.  
This is further categorized into papillary 
thyroid cancer (PTC) (70-75%) and 
follicular thyroid cancer (FTC) (15-20%). 
Undifferentiated carcinomas, which are 
anaplastic cancers, account for <5% of 
thyroid cancers. Medullary carcinoma of the 
thyroid accounts for 5-10% of thyroid 
cancers (3,4). 
FTC is a slowly growing tumor, which is 
common in older age groups, with a peak 
incidence in the fifth decade. Distant 
metastasis has been reported to occur more 
commonly in the bones, brain, and lungs 
(5). The incidence of distant metastasis of 
FTC has been well documented in 
literature and is reported to be between 
11 and 25% (6,7). However, initial 
presentation of this cancer as distant 
metastasis, especially in the spine, has yet 
to be reported. 
We present a case of metastatic FTC, 
whose initial presentation was cauda equina 
secondary to compression by a metastatic 
mass in the lumbar region. 
 
Case Report 
A 52-year-old male was presented to the 
neurosurgery clinic of our hospital with 
complaints of backache for 3 months, 
numbness of the legs for 2 months, and 
weakness of the lower limbs for the last 2 
days. Neurological examination revealed a 
power of 4/5 in both limbs with 
diminished reflexes, decreased anal tone, 
and diminished perianal sensation. 
All laboratory workups, including 
prostate specific antigen, were within 
normal limits. Due to the neurological 
status, an urgent CT-scan of the 
lumbosacral spine with contrast was 
carried out, which showed a soft tissue 
density enhancing expansile lytic lesion 
(55x44 mm) involving the spinous process 
of the L5 vertebra that was causing almost 
complete erosion of the spinous process 
and part of the lamina of the L5 vertebra 
(Fig.1). 
 
Fig 1: A soft tissue density enhancing expansile 
lytic lesion involving the spinous process of the L5 
vertebra  
 
Further workup was carried out, which 
included an ultrasound of the abdomen that 
was reported as normal and a chest x-ray 
that showed a well defined soft tissue 
density in the pleura of the left upper lung 
zone with rib erosion. The patient was sent 
to the operating room on same day as 
admission and underwent an L4-L5-S1 
Laminectomy, excision of the tumor, and 
pedicle screw fixation. 
 Intraoperatively, a mass was observed that 
was soft to firm in consistency, vascular, and 
was eroding the spinous process of L4 and 
L5. Final histopathology revealed a 
metastatic carcinoma most likely of 
thyroidal origin as the specimen showed 
thyroid follicles and was positive for the 
immunohistochemical marker, Thyroid 
transcription factor 1 (TTF1) (Figs.2,3).  
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Fig 2: Low power magnification×10; Follicular 
carcinoma showing multiple variable colloid filled 
thyroid follicles infiltrating into the darkly stained 
bony trabeculae (Lumbar specimen) 
 
Fig 3: Medium power magnification ×20; Follicular 
carcinoma cells showing strong nuclear positivity of 
immunohistochemical marker thyroid transcription 
factor-1 (TTF-1) confirming thyroidal origin. 
Therefore, serum thyroglobulin marker and 
thyroid profile were carried out. Only 
thyroglobulin levels were raised i.e 103 
(normal <55ng/ml). A CT-scan of the neck 
and chest was also carried out, which 
showed a heterogeneously enhancing nodule 
in the left lobe of the thyroid. It measured 
4.3 X 3 cm and another expansile lytic 
lesion involving the left third rib 
posterolaterally was also seen measuring 5 
X 4 cm (Fig.4). 
 
Fig 4: A 4.3 X 3 cm heterogeneously enhancing 
nodule is identified in the left lobe of the thyroid. 
An expansile lytic lesion involving the left third rib 
posterolaterally. is associated with an enhancing 
partly necrotic soft tissue component abutting the 
pleura and measuring 5 X 4 cm  
The patient then underwent total 
thyroidectomy and left thoracotomy with 
excision of the mass along with the third rib. 
Final histopathology revealed a follicular 
carcinoma in the left thyroid and metastatic 
follicular carcinoma in the 3
rd
 rib  
mass (Fig.5). 
 
Fig5: Low power magnification×10; Follicular 
carcinoma showing multiple variable  colloid filled 
thyroid follicles infiltrating into the darkly stained 
bony trabeculae (rib specimen) 
The patient was then given 200mci of 
radioiodine and a post ablative scan was 
performed that showed minimal uptake in 
the lumbar region so another dose of 
200mci was given. Repeat thyroglobulin 
showed a decline from 103 to 13.8ng/ml. 
The patient slowly regained power in his 
limbs with aid of physiotherapy and bowel 
habits returned to normal. At his one year 
of follow up he showed to be symptom 
free and to have resumed his job. 
 
Discussion  
The most common initial presentation of 
thyroid malignancies is a thyroid nodule 
(90%) followed by cervical lymphadeno- 
pathy (5%) and the rest in the lung, bone, 
liver, etc…(2,8). The incidence of bone 
metastasis in DTC is 2-13%. FTC has a 
higher incidence of bone metastasis of        
7–20% as compared to PTC, which has an 
incidence of spinal metastasis of 1–7% 
(9,10). The 10-year survival rate in DTC is   
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80-95%. However, this figure drops to about 
40% when distant metastasis is present (11). 
FTC is known for its hematogenous 
spread secondary to vascular invasion. The 
most frequent site that it can metastasize to 
is the lung followed by bone and lymph 
nodes (7,12). Bone metastasis is more 
frequent in FTC and has been reported in 
7–20% of cases compared to PTC where 
bone metastasis occurs in 1.4-7% of cases 
(2). McCormack however, has reported 
thyroid cancer metastasis to bone varying 
from as low as less than 1% to more than 
40% (13).  
In literature, there are few reports that 
have described distant metastasis as the 
initial presentation of thyroid cancer. Shaha 
et al (6),  from Sloan Kettering Memorial 
Hospital, reported the incidence of distant 
metastasis to be 11% in 1038 patients with 
thyroid cancer, in which 4% of patients had 
an initial presentation of distant metastasis. 
Complete surgical removal of the tumor 
has been reported to offer prolonged 
survival (12). Demura et al (14), in their 
study on 10 patients suffering from thyroid 
cancer with spinal metastasis, showed a 
survival rate of 74% and 25% after 5 and 
10 years respectively via en-bloc resection. 
Local recurrence was reported to be high i.e 
57% in cases who underwent debulking 
compared to a recurrence rate of 10% in 
cases who underwent total en bloc 
spondylectomy. Similarly a retrospective 
study conducted by Bernier et al (15), on 
109 patients among which 68% had spinal 
metastasis, showed that complete spinal 
metastasis surgery on multivariate analyses 
was an independent prognostic indicator of 
improved survival. In our patient, the 
metastatic tumor was completely removed 
from the spine followed by total 
thyroidectomy and complete excision of the 
chest wall metastasis followed by 
radioiodine. After his one-year follow up, 
our patient is well, symptom free, and has 
resumed his job.  
Conclusion 
Diagnosis of metastatic tumors of the 
vertebrae need a thorough work up that 
should include assessment of the thyroid 
gland entailing a detailed clinical history 
and a physical examination. In conclusion, 
for these kinds of rare cases, early 
presentation, proper examination, early 
diagnosis, prompt initiation of treatment 
and follow-up can possibly prolong the 
patient’s life and improve quality of life. 
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